Kevin Ryan - Curriculum Vitae#
Education and qualifications:
- Ph.D., Beatson Institute for Cancer Research (University of Glasgow)
- B.Sc. with Honours in Biochemistry, University of Liverpool
Positions held:
- October 2007-Present: Full Professor of Molecular Cell Biology, University of Glasgow, UK
- March 2007-Present: Senior Group Leader, Cancer Research UK Beatson Institute, UK
- April 2002-April 2008: Cancer Research UK Senior Cancer Research Fellow
- November 2001-February 2007: Junior Group Leader, Cancer Research UK Beatson Institute, UK
- September 1996-October 2001: Post-doctoral fellow, National Cancer Institute, USA
- April 1995-August 1996 Post-doctoral Fellow, Cancer Research UK Beatson Institute, UK
Fellowships/Awards
- 2022 Fellow of the European Academy of Cancer Sciences (EACS)
- 2016 Fellow of the Royal Society of Edinburgh. FRSE.
- 2016 Elected to the European Cell Death Organization (ECDO) Academy
- 2012 Tenovus Medal for excellence in biomedical research. (Information on the medal and previous recipients can be found at: https://www.gla.ac.uk/colleges/mvls/tenovus)
- 2010 European Association for Cancer Research (EACR) ‘Cancer Researcher Award’ – (now renamed the Pezcoller EACR Award).
- 2009 Elected Fellow of the Institute of Biology (now Royal Society of Biology)
- 2002 Certificate of Merit-European Association for Cancer Research
- 2001 Recipient of a CRUK Senior Cancer Research Fellowship
- 2000 NIH Year 2001 Fellows Award for Research Excellence
- 1999 NIH Year 2000 Fellows Award for Research Excellence
Editorial and Scientific Advisory Board Activities and Committee Membership (Selected)
- Editor-in-Chief at Molecular Oncology (FEBS Press) 2021-Present (2020- co-Editor-in-Chief)
- Member and Deputy Chair, Northwest Cancer Research Advisory Group 2018-Present
- Member, Scientific Advisory Board, Danish Cancer Society Research Center. Copenhagen. February 2016 - present
- International Council Member of the NIH Center for Autophagy, Inflammation and Metabolism (AIM) in Disease. University of New Mexico, USA. 2019 - present
- Executive Board Member of the British Association for Cancer Research. 2017 - 2021
- Editorial Board Member for Molecular Cancer Research (AACR) 2017-Present
- Deputy Editor for Oncogene. January 2015 - 2019
- Commissioning Editor for The FEBS Journal. November 2014 - 2019
- Associate Editor’ for Autophagy. August 2011 - Oct 2016.
- Member of judging panel for the 2010 Pontecorvo Prize
Conference Organisation (Selected)
- Chair of the 2019 EMBO Conference on Autophagy in Health and Disease.
- Chair of the ‘Genes and Cancer’ conference 2013-2020 (UK’s longest running cancer meeting)
- Member of the organizing committee for the 2020 European Society for Molecular Oncology (ESMO) Congress, Madrid, Spain.
- Chair of the Beatson International Cancer Conference. 2018-Present
- Member of the organizing committee of the European Cancer Organization (ECCO) ‘Multidisciplinary Cancer Congress (ECCO 17, ESMO 36, ESTRO 32)’ 2013.
Grant Support
Current:
- Cancer Research UK Beatson Institute Core Grant allocation (Nov 2016- Oct2021) - £2,583,179
- Cancer Research UK Early Detection Award (June 2019-June 2023) - £510,900
- Kay Kendall Leukaemia Fund (August 2020-July 2023) - £232,040
Historic:
- Astellas Pharma Inc. $2,000,000 (with Dr. Sharon Tooze, Crick Institute – approximately 50% share between our two labs) – from November 2014 for 2.5 years.
- Worldwide Cancer Research – Project Grant - June 2016-June 2019 - £196,958
- Worldwide Cancer Research – Project Grant - 06/2012-06/2014 - £135,749
- Cancer Research UK Senior Fellowship - 04/2002 – 04/2008 - £715,000
- Cancer Research UK - Project Grant – 01/2005–01/2008 - £131,889
- Cancer Research UK China Fellowship 09/2008 – 09/2011 - £46,518
- Medical Research Scotland Project Grant (joint with Dr. Christine Dufes, University of Strathclyde (12/2009 – 12/2012) - £135,287
- Worldwide Cancer Research – Project Grant – 02/2010-01/2013 - £176783
- Worldwide Cancer Research – Project Grant 01/2011-12/2014 - £169708
Invited Oral Presentations
In the last 10 years, Professor Ryan has been invited to give >120 talks at conferences and research departments in 28 different countries (in Europe, Asia, North America, South America and the Middle East and these have included several Keynote/Named lectures. These talks included invitations to prestigious meetings including those organized by: Keystone Symposia, Gordon Research Conferences, AACR, EACR, EMBO, ECCO, ESMO, Cold Spring Harbor, Cold Spring Harbor Banbury Center and The Nobel Foundation.
Peer Review Activities
Acted as a referee for manuscripts submitted for publication in:
Nature, Science, Cell, Cancer Cell, Molecular Cell, Developmental Cell, Cell Metabolism, Cell Reports, Nature Cell Biology, Genes & Development, Science Signaling, Science Translational Medicine, Proceedings of the National Academy of Sciences, USA, The EMBO Journal, EMBO Reports, EMBO Molecular Medicine, Nature Reviews Cancer, Nature Reviews Clinical Oncology, Nature Reviews Immunology, Nature Reviews Neurology, Nature Reviews Drug Discovery, Nature Communications, The Journal of Cell Biology, The Journal of Clinical Investigation, Molecular and Cellular Biology, Nature Protocols, Current Biology, PLoS Genetics, PLoS Biology, PLoS Pathogens, PLoS One, Aging Cell, Oncogene, Genome Biology, The Journal of Biological Chemistry, The Journal of Cell Science, The Journal of General Physiology, The American Journal of Pathology, The American Journal of Physiology, Cancer Research, Cancer Discovery, Cell Death and Differentiation, Disease Models & Mechanisms, The Journal of Virology, Molecular Biology of the Cell, Nucleic Acids Research, Scientific Reports (Nature), Experimental Cell Research, Molecular Medicine, Molecular Systems Biology, Hepatology, Clinical and Experimental Metastasis, Journal of the Royal Society Interface, Progress in Neurobiology, Cell and Molecular Life Sciences, BBA Reviews on Cancer, BBA BMC-Cancer, Trends in Cell Biology, Autophagy, Apoptosis, Molecular Cancer Research, Drug Resistance Updates, Clinical Cancer Research, Molecular Cancer Therapeutics, Human Gene Therapy, The Journal of Pathology, Medical Oncology, Molecular Cancer, Cancer Letters, The British Journal of Cancer, The British Journal of Pharmacology, Biochemical Pharmacology, Molecular Pharmacology, Cell Research, Proteomics, Journal of Molecular Medicine, Cell and Molecular Biology Letters, International Journal of Cancer, Cell Division, FEBS Journal, European Journal of Cancer, Gastroenterology, The Biochemical Journal, Physiological Reviews, The Journal of Cellular Biochemistry, Cell Viology and Toxicology, Journal of Molecular and Genetic Medicine, Carcinogenesis, Molecular Carcinogenesis, Molecular and Cellular Oncology, Acta Oncologica, International Journal of Molecular Sciences, Biotechnology Progress.
In addition, invited to review grant applications for:
The Wellcome Trust, UK; The Academy of Medical Sciences, UK; Medical Research Council, UK; Worldwide Cancer Research, UK; European Research Council (ERC); Biotechnology and Biological Sciences Research Council, UK; The Royal Society, UK; City University of New York (CUNY) Collaborative Incentive Research Program; Leukaemia and Lymphoma Research, UK; Breast Cancer Now, UK; North West Cancer Research Fund, UK; The International Union Against Cancer; The Alzheimer's Research Trust, UK; Health Research Board of Ireland; Qatar National Research Fund; Italian Association for Cancer Research; Luxembourg National Research Fund; Agence Nationale Recherche, France; Fondation pour la Recherche Médicale, France ; Austrian Academy of Sciences; Austrian Science Fund (FWF); Foundation for Polish Science; Danish Cancer Society; The Prostate Cancer Society; Israel Science Foundation; Tenovus, UK; The Lister Institute of Preventative Medicine, UK; Cancer Research UK; National Medical Research Council of Singapore; Research Foundation – Flanders; Health Research Council of New Zealand; The Cunningham Trust, UK; Lundbeck Foundation, Denmark; Novo Nordisk Foundation, Denmark; The Netherlands Organisation for Scientific Research (NOW).
Involved in panel reviews/ tenure reviews /5-year reviews at the following institutions:
National University of Singapore; University of Dundee, UK; University of Oxford, UK; Baylor College of Medicine, Houston, USA; BC Cancer Agency, Canada; Fred Hutchinson Cancer Research Center, Seattle, USA; University College London, UK; University of Antwerp, Belgium; Icahn School of Medicine at Mt. Sinai, NY, USA; The University of Sheffield, UK; Simon Fraser University, Vancouver. Canada; The Medical Research Council, UK; The University of Victoria, British Columbia, Canada; University of Newcastle, UK; University of Cambridge; University of Bristol, University of Lancaster, BBSRC, The Chinese University of Hong Kong; St. Jude Children’s Research Hospital, USA; Ludwig Cancer Research, USA; University of Cologne, Germany.
Promotion of Junior Scientists – notable lab alumni:
- Dr. Vignir Helgason (former graduate student) – now PI in the Wolfson Wohl Cancer Research Centre, Glasgow, UK
- Dr. Mah Li Yen (former graduate student) – appointed lecturer at the International Medical University, Kuala Lumpur, Malaysia
- Dr. Simon Wilkinson (former post-doc) – now PI at the University of Edinburgh Cancer Centre, UK
- Dr. Laurence Lao (former post-doc) – appointed Professor at Shanghai University, China
- Dr. Mathias Rosenfeldt (former clinical fellow and graduate student) – now a faculty member at the University of Würzburg, Germany
- Dr. Jun-ichi Sakamaki (former post-doc) – currently Assistant Professor, University of Tokyo
- Dr. Florian Beaumatin (former post-doc) – now PI at the University Pau/INSERM, France
Publications - including articles in press
First author: 11 Last author: 70 Total:121 Citations: >20,000 H-index: 54